• Among hospitalized patients, a diagnosis of acute kidney injury was linked to worse patient outcomes after hospital discharge.
• Results from the study will be presented online at ASN Kidney Week 2021 November 4–November 7.
• New research indicates that substantial discrepancies exist between eGFR and mGFR, which are different assessments of kidney function, even in an individual patient.
• Results from the study will be presented online at ASN Kidney Week 2021 November 4–November 7.
• Investigators found that the Kidney Disease Risk Equation can predict a patient’s likelihood of developing chronic kidney disease, based on readily available information.
• Results from the study will be presented online at ASN Kidney Week 2021 November 4–November 7.
• Certain factors may explain why men are more likely than women to develop kidney stones.
• The gap between men and women in terms of risk of stones is getting smaller.
• Results from the study will be presented online at ASN Kidney Week 2021 November 4-November 7.
• Among adults with hypertension, air pollution exposure was not linked with blood levels of Galectin 3, a marker of scarring in the heart; however, in adults who also had chronic kidney disease, air pollution exposure was associated with rising levels of Galectin 3.
• Results from the study will be presented online at ASN Kidney Week 2021 November 4–November 7.
• Researchers have identified several metabolites in the blood whose levels are altered by coffee consumption.
• Levels of 3 of these coffee-related metabolites were significantly associated with individuals’ risk of developing chronic kidney disease.
In a study of children on the U.S. kidney transplant list from 2008 to 2019, researchers found no racial and ethnic disparities regarding time on the waitlist until transplantation either before or after a 2014 policy change.
Chronic kidney disease (CKD) is a global health crisis with an estimated 850 million affected individuals. The State of the Global Nephrology Workforce: A Joint ASN–ERA-EDTA–ISN Investigation addresses whether there are enough kidney doctors—or nephrologists available to care for the growing number of people around the world with CKD, and whether their training is adequate. The investigation was conducted by the American Society of Nephrology (ASN), European Renal Association (ERA), and International Society of Nephrology (ISN).
Clinical equations that estimate patients’ kidney function include an adjustment for Black race. This survey-based study found that U.S. transplant centers agree that this adjustment is unsatisfactory.
During 2015–2021, Medicare implemented an initiative that offered financial incentives for enhanced care coordination and patient outcomes among providers treating Medicare beneficiaries with kidney failure.
Patients with kidney failure who were affected by dialysis facility closures between 2001 and 2014 experienced 7% to 9% higher rates of hospitalizations compared with similar patients at facilities that did not close.
A recent study examined the spectrum of antibody responses—including IgG, IgM, and IgA antibodies—in kidney transplant recipients infected with the virus that causes COVID-19
Today, the National Kidney Foundation (NKF) and the American Society of Nephrology (ASN) Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Diseases has released its final report, which outlines a new race-free approach to diagnose kidney disease.
Today, advocates of the American Society of Nephrology (ASN) and 19 other kidney health professional and patient organizations are meeting with their congressional delegations, calling on them to enact policies to improve kidney health
Most surveyed family members of patients with kidney failure on long-term dialysis reported they had spoken with the patient about their end-of-life wishes but not about stopping dialysis or initiating hospice.
• The Patient Activation Measure describes an individual’s knowledge, ability, skills, and confidence in self-managing chronic conditions.
• A recent study examined the measure’s relevance for patients with kidney failure who are undergoing long-term dialysis.
The National Kidney Foundation (NKF) and the American Society of Nephrology (ASN) congratulate the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Diseases for submitting its final report for publication.
• In individuals with kidney disease, those with high body mass index variability faced higher risks of needing kidney replacement therapy, experiencing a heart attack, experiencing a stroke, and dying prematurely.
• Pooled results from phase 3 clinical trials demonstrate that roxadustat is efficacious and may be comparable to placebo in studies done to date for treating anemia in patients with chronic kidney disease who do not require dialysis.